Discover if this is a suitable investor for your startup. If they are we'll make a warm introduction for free. Otherwise, we'll connect you with matching investors.
Seroba is a European life sciences venture capital firm founded in 2011 and headquartered in Dublin, Ireland. The firm has established itself as a key player in the early-stage investment landscape, particularly in the biotech and medtech sectors. Since its inception, Seroba has backed a total of 32 companies, contributing to the development of 20 new medical devices and 8 new therapeutics that have reached the market.
With a fund size of $134 million, Seroba operates with a hands-on approach, providing strategic guidance and operational support to its portfolio companies. The firm has expanded its presence beyond Dublin, with offices in Milan and Paris, allowing it to tap into a broader European market. Its limited partners include notable institutions such as the European Investment Fund and the Ireland Strategic Investment Fund, reflecting strong confidence in its investment strategy.
Seroba invests primarily in early-stage and clinical-stage companies within the life sciences sector, with a strong emphasis on biotechnology and medical technology. The firm targets innovations that address unmet medical needs, aiming to improve patient outcomes significantly. Investment stages include pre-seed, seed, and Series A, allowing Seroba to engage with companies at various points in their development.
The firm typically seeks to invest in companies that demonstrate a clear potential for breakthrough solutions in healthcare. This includes a focus on disease-modifying therapeutics and medical devices that can significantly enhance treatment options for patients. Seroba's geographic focus is predominantly on Western Europe, with selective investments in North America, ensuring a broad reach in the life sciences market.
Seroba's portfolio includes a diverse range of companies that are making significant strides in the life sciences sector. Notable portfolio companies include:
These companies exemplify Seroba's commitment to supporting innovations that can lead to significant improvements in healthcare.
Jeanne Bolger - Venture Partner. Jeanne has extensive experience in the life sciences sector, focusing on investment strategies and portfolio management.
Anita Dipalo - Accountant. Anita manages the financial operations of the firm, ensuring compliance and financial integrity.
Andrew Duignan - CFO Partner. Andrew oversees financial strategy and operations, bringing a wealth of experience from previous roles in venture capital.
Ciara Green - Operations Manager. Ciara is responsible for the day-to-day operations of the firm, streamlining processes to enhance efficiency.
Sophie Hughes - Investment Analyst. Sophie conducts market research and analysis to support investment decisions and portfolio management.
To pitch Seroba, founders should send an email to info@serobavc.com. It is essential to include a comprehensive pitch deck that outlines the startup's mission, market opportunity, competitive landscape, and team qualifications. Founders should expect a response within a few weeks, and warm introductions are preferred but not mandatory.
On April 23, 2026, Seroba announced the final close of its Fund IV at €123 million ($134 million), exceeding its target. This fund will focus on early-stage investments in life sciences, with commitments to five companies including Perfuze and Sibylla Biotech.
In recent months, Seroba has been actively involved in supporting its portfolio companies, helping them navigate the challenges of bringing new medical devices and therapeutics to market. The firm continues to strengthen its position in the European venture capital landscape.
What are Seroba's investment criteria?
Seroba focuses on early-stage and clinical-stage companies in the life sciences sector, particularly in biotechnology and medical technology. The firm looks for innovations that address unmet medical needs and have the potential to improve patient outcomes.
How can I pitch to Seroba?
Founders can reach out to Seroba via email at info@serobavc.com. It is advisable to include a detailed pitch deck that outlines the business model, market opportunity, and team background.
What makes Seroba different from other venture capital firms?
Seroba distinguishes itself through its hands-on approach, providing operational support and strategic guidance to portfolio companies. The firm has a strong track record of helping companies reach commercial milestones.
What is the geographic scope of Seroba's investments?
Seroba primarily invests in Western Europe, with selective investments in North America. This geographic focus allows the firm to leverage local market knowledge while accessing broader opportunities.
What is the typical check size for investments?
While specific check sizes are not disclosed, Seroba typically invests in early-stage rounds, which can range from pre-seed to Series A funding stages.
What kind of post-investment involvement does Seroba have?
Seroba maintains a hands-on approach post-investment, providing strategic guidance, operational support, and access to a network of industry contacts to enhance the growth of its portfolio companies.
All trademarks, logos and brand names are the property of their respective owners. All company, product and service names used in this website are for identification purposes only. Use of these names, trademarks, and brands does not imply endorsement.